2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline

C198H132N12O6 — CID 157361968

IUPAC2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline
SMILESCOc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cccnc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5ccncc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cnccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4cnc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ncc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3cnc4ccc5ncccc5c4c3)c3ccccc23)cc1
InChIInChI=1S/6C33H22N2O/c1-36-24-17-14-21(15-18-24)30-25-8-2-4-10-27(25)31(28-11-5-3-9-26(28)30)29-19-16-23-13-12-22-7-6-20-34-32(22)33(23)35-29;1-36-23-17-14-21(15-18-23)31-24-8-2-4-10-26(24)32(27-11-5-3-9-25(27)31)30-19-16-22-20-34-29-13-7-6-12-28(29)33(22)35-30;1-36-23-14-12-21(13-15-23)32-25-7-2-4-9-27(25)33(28-10-5-3-8-26(28)32)22-19-29-24-11-6-18-34-30(24)16-17-31(29)35-20-22;1-36-24-15-12-21(13-16-24)31-26-6-2-4-8-28(26)32(29-9-5-3-7-27(29)31)30-17-14-22-10-11-23-20-34-19-18-25(23)33(22)35-30;1-36-24-15-12-22(13-16-24)31-25-6-2-4-8-27(25)32(28-9-5-3-7-26(28)31)30-17-14-23-11-10-21-18-19-34-20-29(21)33(23)35-30;1-36-23-16-14-21(15-17-23)31-25-10-4-6-12-27(25)32(28-13-7-5-11-26(28)31)29-18-19-30-33(35-29)24-9-3-2-8-22(24)20-34-30/h6*2-20H,1H3
InChIKeyBISZGNSAKJVSDH-UHFFFAOYSA-N
MW2775.31 g/mol
LogP50.59
Rot. Bonds18

About 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline

2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline (PubChem CID 157361968) has the molecular formula C198H132N12O6 and a molecular weight of 2775.31 g/mol. Its IUPAC name is 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline.

Molecular Properties

Compound Name2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline
PubChem CID157361968
Molecular FormulaC198H132N12O6
Molecular Weight2775.31 g/mol
Exact Mass2773.04
IUPAC Name2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline
SMILESCOc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cccnc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5ccncc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cnccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4cnc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ncc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3cnc4ccc5ncccc5c4c3)c3ccccc23)cc1
InChIInChI=1S/6C33H22N2O/c1-36-24-17-14-21(15-18-24)30-25-8-2-4-10-27(25)31(28-11-5-3-9-26(28)30)29-19-16-23-13-12-22-7-6-20-34-32(22)33(23)35-29;1-36-23-17-14-21(15-18-23)31-24-8-2-4-10-26(24)32(27-11-5-3-9-25(27)31)30-19-16-22-20-34-29-13-7-6-12-28(29)33(22)35-30;1-36-23-14-12-21(13-15-23)32-25-7-2-4-9-27(25)33(28-10-5-3-8-26(28)32)22-19-29-24-11-6-18-34-30(24)16-17-31(29)35-20-22;1-36-24-15-12-21(13-16-24)31-26-6-2-4-8-28(26)32(29-9-5-3-7-27(29)31)30-17-14-22-10-11-23-20-34-19-18-25(23)33(22)35-30;1-36-24-15-12-22(13-16-24)31-25-6-2-4-8-27(25)32(28-9-5-3-7-26(28)31)30-17-14-23-11-10-21-18-19-34-20-29(21)33(23)35-30;1-36-23-16-14-21(15-17-23)31-25-10-4-6-12-27(25)32(28-13-7-5-11-26(28)31)29-18-19-30-33(35-29)24-9-3-2-8-22(24)20-34-30/h6*2-20H,1H3
InChIKeyBISZGNSAKJVSDH-UHFFFAOYSA-N
XLogP50.59
TPSA210.06 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds18
Heavy Atoms216
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002775.31
LogP ≤ 550.59
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_2', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-(4-Methoxyphenyl)-3-phenylbenzo[f][1,7]naphthyridine
CID 132849958
1-(4-Methoxyphenyl)-3-naphthalen-1-ylbenzo[f][1,7]naphthyridine
CID 137647266
1-(4-Methoxyphenyl)-3-naphthalen-1-ylbenzo[f][1,7]naphthyridine;hydrochloride
CID 137650520
N,N-bis[(2-methoxy-5,7-dimethylquinolin-3-yl)methyl]-1-pyridin-2-ylmethanamine
CID 162657760
N,N-dimethyl-3-[4-(1,10-phenanthrolin-4-yl)butoxy]aniline;bis(2-pyridin-2-ylpyridine)
CID 72199317
CU(Dap)2 chloride
CID 60144211
28-Ethoxy-6,12,15,21,24,32-hexazaoctacyclo[23.7.1.02,23.05,22.07,20.08,13.014,19.029,33]tritriaconta-1(32),2(23),3,5(22),6,8(13),9,11,14(19),15,17,20,25(33),26,28,30-hexadecaene
CID 45268627
3-[2,4-Bis(trifluoromethyl)phenyl]-1-(4-methoxyphenyl)benzo[f][1,7]naphthyridine
CID 137651159
1-(4-Methoxyphenyl)-3-naphthalen-2-ylbenzo[f][1,7]naphthyridine
CID 137652202
3-(4-Methoxynaphthalen-1-yl)-1-(4-methoxyphenyl)benzo[f][1,7]naphthyridine
CID 137652530
3,4-Bis(4-methoxyphenyl)-6-methyl-5,6,15,22-tetrazapentacyclo[12.8.0.02,7.08,13.016,21]docosa-1(22),2(7),4,8,10,12,14,16,18,20-decaene
CID 164625904
4-(4-Methoxyphenyl)-2-[4-(trifluoromethyl)phenyl]-1,5-naphthyridine
CID 139095340

Frequently Asked Questions

What is the IUPAC name of 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline?
The IUPAC name of 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline (CID 157361968) is 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline.
What is the SMILES notation for 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline?
The canonical SMILES for 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline is COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cccnc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5ccncc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ccc5cnccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4cnc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3ccc4ncc5ccccc5c4n3)c3ccccc23)cc1.COc1ccc(-c2c3ccccc3c(-c3cnc4ccc5ncccc5c4c3)c3ccccc23)cc1.
What is the InChIKey of 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline?
The InChIKey is BISZGNSAKJVSDH-UHFFFAOYSA-N. The full InChI is InChI=1S/6C33H22N2O/c1-36-24-17-14-21(15-18-24)30-25-8-2-4-10-27(25)31(28-11-5-3-9-26(28)30)29-19-16-23-13-12-22-7-6-20-34-32(22)33(23)35-29;1-36-23-17-14-21(15-18-23)31-24-8-2-4-10-26(24)32(27-11-5-3-9-25(27)31)30-19-16-22-20-34-29-13-7-6-12-28(29)33(22)35-30;1-36-23-14-12-21(13-15-23)32-25-7-2-4-9-27(25)33(28-10-5-3-8-26(28)32)22-19-29-24-11-6-18-34-30(24)16-17-31(29)35-20-22;1-36-24-15-12-21(13-16-24)31-26-6-2-4-8-28(26)32(29-9-5-3-7-27(29)31)30-17-14-22-10-11-23-20-34-19-18-25(23)33(22)35-30;1-36-24-15-12-22(13-16-24)31-25-6-2-4-8-27(25)32(28-9-5-3-7-26(28)31)30-17-14-23-11-10-21-18-19-34-20-29(21)33(23)35-30;1-36-23-16-14-21(15-17-23)31-25-10-4-6-12-27(25)32(28-13-7-5-11-26(28)31)29-18-19-30-33(35-29)24-9-3-2-8-22(24)20-34-30/h6*2-20H,1H3.
What are the key properties of 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline?
2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline has a molecular weight of 2775.31 g/mol, XLogP of 50.59, 18 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[c][1,5]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]benzo[h][1,6]naphthyridine;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,8-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,9-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-1,10-phenanthroline;2-[10-(4-methoxyphenyl)anthracen-9-yl]-4,7-phenanthroline is sourced from PubChem (CID 157361968), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).